Login

Hendrik Bischof from HUBER+SUHNER discusses his role in Group Strategy and M&A and his experiences working at the company. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"1970s Market Déjà Vu - A Dialogue with Jim Rogers " | Ronald Chan, Chartwell Capital Limited
00:10:00
investing in founders that leverage exponential technologies & hard science to make humanity more resilient|Matthew McGraw,Founder and Managing Partner,Anthropocene Ventures
00:00:00
Bio-Works CEO, Jonathan Royce, interview - Jonathan Royce Chief Executive Officer, Bio-Works Technologies
00:10:00
CoreSafe at Work: Fosterville Gold Mine's Core Tray System in Action | JESSICA KEAST , DIRECTOR of CoreSafe Core Trays
00:10:00
James Hill Discusses Singular Health’s Vertically Integrated Medical Business | James Hill, COO , Singular Health Group Ltd.
00:10:00
Rosario Pingaro, President and CEO of Convergenze SpA, Reflects on the Company's Journey | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Steppe Gold: Strategic Expansion and Robust Financial Growth in Mongolia
00:10:00
"Approaching Outsourced Chief Investment Officers (OCIOs) and Multi-Asset Businesses: Insights from Floyd Simpson at PFM Asset Management"
00:00:00
Oncimmune's strategic pivot aims for robust growth in 2024 - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:10:00
CEO traces path from undergrad cancer biology interest to oncology biotech leadership | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
Boosted by strong performance, Baader Bank AG's stock is discussed alongside 7C Solarparken CEO Steven De Proost's insights on goals, growth, and directors' dealings in SdK Talk.
00:10:00
A-Mark Precious Metals CEO Greg Roberts Discusses Market Trends and Strategic Goals | Greg Roberts, CEO , A-Mark Precious Metals .

© 2017 - Neuhu+